Is GDRX stock a Buy, Sell, or Hold?

Based on our analysis, GDRX is currently a WAIT with low confidence. 📊 MIXED SIGNALS: GDRX shows conflicting indicators. Wait for confirmation before entering.

What is the fair value of GDRX stock?

Our analysis estimates the fair value range for GDRX to be between $3.39 and $3.69. The current price is $3.39.

What is the analyst price target for GDRX?

The average Wall Street analyst price target for GDRX is $4.03. This implies a potential upside of 18.9% from current levels.

GoodRx (GDRX) Stock: Buy, Sell, or Hold?

GDRX - GoodRx Holdings, Inc. Class A Common Stock

SERVICES-COMPUTER PROCESSING & DATA PREPARATION

$3.39

0.04 (1.19%) ▲

5d: -3.97%

30d: -5.57%

90d: +28.9%

WAIT

LOW Confidence

Protect Your GDRX Gains

Analysis Updated: Sep 11, 2026 12:00 AM ET

Earnings: Nov 03, 2026

Smart Money Accumulation

Options open interest is building while the stock consolidates - a pattern consistent with institutional accumulation. View Scanner →

Signal fired Sep 3, 2026 at $3.53 · last confirmed Sep 9, 2026

Strength: 8.6/10

Get Alerted When GDRX Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.

100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading historical data...

💡

Bottom Line:
📊 MIXED SIGNALS: GDRX shows conflicting indicators. Wait for confirmation before entering.

See Forward Earnings Fair Value & Price Prediction →

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

Adjust Growth Assumption: 17.3%

0% (Stagnation) 50% (Hyper Growth)

EST. PRICE IN 2031

$4.18

Based on 10.7% avg growth

INTRINSIC VALUE TODAY

$2.59

Trading above historical range

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 7.1x Exit PE.

View Full DCF Model

In-depth Analysis How we analyze

Valuation Analysis: GDRX is currently trading at $3.39, which is considered oversold relative to its 30-day fair value range of $3.39 to $3.69. From a valuation perspective, the stock is trading at a premium (Forward PE: 9.5) compared to its historical average (7.1). At these levels, the market is pricing in 10.1% annual earnings growth.

Technical Outlook: Technically, GDRX is in a strong uptrend. Immediate support is located at $3.28, while resistance sits at $3.60.

Market Sentiment: GDRX scores 24/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $4.03 (+18.9%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position OVERSOLD

Historical Trading Range $3.39 - $3.69

Company Quality Score 42/100 (HOLD)

Volume Confirmation HIGH

Confidence Score 58.1%

Protect Your Profits

Holding GDRX? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

BULLISH: Price oversold vs 30-day range
BEARISH: Weak technical setup (24/100)
BULLISH: High volume confirmation
BULLISH: Trading below Wall St target ($4.03)
BULLISH: Expecting earnings turnaround to 10.1% growth with -1.3% revenue growth
WARNING: Composite score 42/100 in the bottom quintile — this cohort historically lags the market

Trading Range Analysis

30-Day Trading Range $3.39 - $3.69

Current vs Trading Range OVERSOLD

Support & Resistance Levels

Support Level $3.28

Resistance Level $3.60

Current Trend Strong Uptrend

Technical data as of Sep 11, 2026

Fundamental Context

Forward P/E (Next Year Est.) 9.51

Wall Street Target $4.03 (+18.9%)

Revenue Growth (YoY) -1.3%

Earnings Growth (YoY) -44.5%

Profit Margin 2.1%

Valuation Premium vs History +10.1% premium

PE vs Historical 9.5 vs 7.1 STRETCHED

Market-Implied Price Targets If current PE multiple persists

Implied Growth (YoY): +10.1% (market-implied from PE analysis)

1-Year Target $3.73 (+10%)

2-Year Target $4.11 (+21%)

3-Year Target $4.52 (+34%)

3-Yr Target (if PE normalizes) (PE: 10→7) PE COMPRESSION $3.38 (0%)

Earnings growth offset by PE compression

3-Year Scenarios Using analyst projected EPS growth

Bull: (PE: 20.2, Growth: 17.3%) $11.61 (+242%)

Base: (SPY PE: 9.5, Growth: 17.3%) $5.47 (+62%)

Bear: (PE: 7.1, Growth: 17.3%) $4.09 (+21%)

📈 Valuation based on Current Earnings

Forward PE: 5.44 | Forward EPS (Implied): $0.62

Bull Case $4.09 (+21%)

Analyst growth 15.0%, PE expands to 5.7

Base Case $3.39 (0%)

Market implied 0.0%, PE stable at 5.4

Bear Case $2.59 (-24%)

Severe decline -15.0%, PE contracts to 4.9

These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.

Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit

bloggers & journalists: you are free to use our charts with attribution.

Last updated: September 12, 2026 2:59 AM ET
Data refreshes hourly during market hours. Next update: 3:59 AM

🔥 Top Stocks Breaking Out Now

Ticker	Score	Recommendation	Change %

See Full Scanner Results »

Technical Signals Check

Is GDRX showing a specific setup today?

RSI Divergence Check TTM Squeeze Check MACD Crossover Check Gamma Walls Check Unusual Activity Check

Insider Activity (6 Months)

Buys

Sells

Net

NEUTRAL

View Insider Activity Scanner

Unlock Insider Activity

See real-time buying/selling by company executives for GDRX.

Create Free Account

Already have an account? Log In

Top Rated Health Information Services Stocks

Top-rated stocks in Health Information Services by analyst ratings.

Stock	Analyst Consensus	Analyst Target	Tradestie Score
VEEV Veeva Systems Inc Class A	BUY 32 analysts	$294	39 SELL
PRVA Privia Health Group Inc	STRONG BUY 21 analysts	$32	42 HOLD
GEHC GE HealthCare Technologi…	STRONG BUY 21 analysts	$90	49 HOLD
PHR Phreesia Inc	STRONG BUY 15 analysts	$14	51 HOLD
WAY Waystar Holding Corp. Co…	STRONG BUY 13 analysts	$33	45 HOLD

VEEV Veeva Systems Inc…

39 SELL

PRVA Privia Health Gro…

42 HOLD

GEHC GE HealthCare Tec…

49 HOLD

PHR Phreesia Inc

51 HOLD

WAY Waystar Holding C…

45 HOLD

Advanced GDRX Option Strategies

Professional options setups generated by AI based on today's GDRX price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for GDRX

GDRX Technical Chart GDRX Price Prediction GDRX Earnings Date GDRX Investment Advisor GDRX Fair Price Analyzer GDRX Options Advisor GDRX Options Chain GDRX Options Analysis GDRX Competitors

Compare GDRX with Peers

GDRX vs AMWL
Which one to buy?

GDRX vs FROG
Which one to buy?

GDRX vs ASAN
Which one to buy?

GDRX vs NCNO
Which one to buy?

GDRX vs GTM
Which one to buy?

GDRX vs SAIH

GDRX vs WEAV

EVH vs GDRX

FROG vs GDRX
Winner: GDRX

TEM vs GDRX
Winner: GDRX

ABCS vs GDRX

FORA vs GDRX

NCNO vs GDRX
Winner: NCNO

CARS vs GDRX

GDRX vs APLD

Create New Comparison View All Competitors

Tradestie